Sage Therapeutics Inc.

(SAGE) Trade

By |

Profile

Sage Therapeutics Inc is a biopharmaceutical company conducting development programs and clinical trials to discover medicines for central nervous system disorders. It has development programs for refractory status epilepticus, and Parkinson's di-sease.

Contact Information

Website: www.sagerx.com
Main Phone: +1 617 299-8380
Address: 215 First Street
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: NSD
CEO: Jeffrey M. Jonas
Employees: 257
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 164.94 $ 0. (0.00%)
Last Price 164.94 Change $ 0. Change % 0.00 Tick N/A
Bid 160.00 Bid Size 100.00 Ask 165.00 Ask Size 100.00
Open N/A High N/A Low N/A Prev Close 164.94
Last Trade Volume 1 52 Wk Hi 195.97 52 Wk Low 59.57
Market Cap 7.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 46,515,858.00 EPS (TTM) -7.25 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 23 58
Number of Buys 1 5
Number of Sells 22 53
Net Activity -99935 -2147628
Last 10 Buys Shares
Jeffrey M. Jonas 1,000
Kimi Iguchi 1,000
Stephen J. Kanes 1,000
James M. Frates 1,000
Albert J. Robichaud 1,000
Steven M. Paul 1,000
Kimi Iguchi 1,000
Last 10 Sell Shares
James M. Frates 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 225 225 225 261
Low Target Price Estimate 112 112 112 193
Mean Target Price Estimate 195.57 195.57 195.57 214.6
Standard Deviation 35.74 35.74 35.74 16.94
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 06/14/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 11 10 10 10
Moderate Buy 1 2 2 2
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.04 1.13 1.13 1.13